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Background: Flos Genkwa (yuanhua in Chinese), the dried flower buds of Daphne genkwa Sieb.et Zucc.
(Thymelaeaceae), is a traditional Chinese medicinal herb mainly used for diuretic, antitussive, expectorant, and
anticancer effects. However, systematic and comprehensive studies on Flos Genkwa and its bioactivity are limited.
Results: After confirmation of the anti-tumor activity, the 95% ethanolic extract was subjected to successive solvent
partitioning to petroleum ether, dichloromethane, n-butanol, and water soluble fractions. Each fraction was tested
using the same biological activity model, and the dichloromethane fraction had the highest activity. The
dichloromethane fraction was subjected to further chromatographic separation for the isolation of compounds
1–13. Among the 13 compounds, the diterpene esters (compounds 10–13) showed anticancer activity, whereas the
flavonoids, lignanoids, and peptides showed moderate activity. Compound 13 was a new daphnane diterpenoid,
which was named genkwanin VIII.
The preliminary antitumor mechanism of yuanhuacine was studied by protein expression and cell cycle analysis in
MCF-7 cancer cells.
Conclusion: The present investigation tends to support the traditional use of Flos Genkwa for treating cancer.
Through bioassay-guided fractionation and isolation techniques, the CH2Cl2 fraction was determined as the active
fraction of the flower buds of D. genkwa, and the anti-tumor activity was ascribable to the compounds 10–13.
Keywords: Daphne genkwa, Antitumor, MTT, Flow cytometric, Western blotBackground
Flos Genkwa, the dried flower buds of Daphne genkwa,
is a commonly used traditional Chinese medicine (TCM)
known to have purgative and diuretic effects, which
helps to remove fluid retention [1]. Flos Genkwa is also
used as abortifacient [2] and expectorant [3]. As a trad-
itional Chinese toxic herb, this medicine possesses anti-
cancer effect [4-6], based on an important proposition of
TCM theory “Fighting fire with fire” (Poisonous Chinese
herbal medicine for cancer therapy). In clinical applica-
tions, this TCM has been used as “Shi-Zao-Tang” to* Correspondence: chouguixin@yahoo.com.cn; zlyu@hkbu.edu.hk
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reproduction in any medium, provided the ortreat malignant ascites [7,8], as “San-Leng-Jian-Wan” to
treat tumor models of human ovarian cancer [9], and in
a sticking-plaster formula to treat malignant pleural ef-
fusion, malignant ascites, and icterus [10]. The material
basis of the antitumor activity needs to be investigated.
Various flavonoids, daphnane-type diterpene ester
[11,12], lignanoid, coumarins, and amides [13,14] have
been identified in D. genkwa. Recent studies have
reported that total flavonoids inhibited the growth of
Lewis lung carcinoma in C57BL6 mice [15]. (−)-Sy-
ringaresinol potently inhibited the proliferation of hu-
man promyelocytic HL-60 cells through G1 arrest and
apoptosis induction [16]. Daphnoretin caused human
osteosarcoma (HOS ) cell cycle arrest in the G2/M
phase and triggered the caspase-3-dependent apoptotic
pathway [17]. Yuanhuadine inhibited growth against
human lung cancer cells and cell cycle arrest in the G0/
G1 and G2/GM phases with the up-regulation of p21 and. This is an Open Access article distributed under the terms of the Creative
commons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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expressions [18]. However, thus far the systematic research
on the constituents responsible for the anticancer activity
of the plant remains unclear. Thus, the potential
antitumor chemotherapeutic activity of Flos Genkwa
needs to be ascertained.
In the present study, the anticancer ability of the
extracts, fractions, and compounds obtained through
activity-guided fractionation were studied in vivo and
in vitro, to elucidate the role of anticancer compounds
in this plant. The chemical structures were established
using NMR spectroscopic, mass-spectral analyses, and
published data. Thirteen compounds were isolated
from the dichloromethane fraction, which had the
highest activity, and their structures were elucidated
to be daphnoretin (1) [19], genkwanin (2), 3′-hydro-
xygenkwanin (3) [20], apigenin (4) [21], tiliroside (5)
[22], pinoresinol (6) [23], syringaresinol (7) [24], lari-
ciresinol (8) [25], aurantiamide acetate (9) [26], yuan-
huacine (10), yuanhuadine (11) [4], genkwanine III (12)
[27], and genkwanine VIII (13). The inhibitory activities
of these compounds were investigated on nine tumor
cells in vitro by MTT assay, and the results indicated
that daphnane-type diterpene esters (10–13) showed
significant antitumor activity (Table 1). To the best of
our knowledge, this is the first report on the isolation of
cytotoxic compounds from D. genkwa against MCF-7,
HT-29, MDA-MB-231, Huh 7, Colo 205, AGS, A 2058,
and B 16 cell lines. Yuanhuacine was one of the com-
pounds that exhibited potent cytotoxic activities. Further-
more, the mechanism of action of yuanhuacine against
MCF-7 was studied using flow cytometry and Western
blot analysis.Table 1 Cytotoxic effects of the tested compounds
Huh 7 A 2058 B 16 231
Yuanhuacine >60 15 18 20
Genkwanine III >60 54 >60 >60
Genkwanine VIII >60 58 >60 >60
Yuanhuadine 13 12 11 19
Daphnoretin 48 17 13 >60
Genkwanin 56 >60 – >60
3'-hydroxygenkwanin >60 21 – >60
Tiliroside >60 >60 – >60
Apigenin >60 >60 – >60
Pinoresinol >60 >60 – >60
Syringaresinol >60 >60 – >60
Lariciresinol >60 >60 – >60
Aurantiamide acetate >60 >60 – 56
Table 1: Inhibitory effects of the compounds from dichloromethane fraction of the
HT-29, A 549, A 2058 and B 16 cells. Cells were treated with 0–20 μg/mL of extractsResults and discussion
Isolation and identification
The dried flower buds of D. genkwa (20.0 kg) were
extracted with 9% ethanol extensively at room tem-
perature and evaporated to dryness to yield a dark
crude ethanol extract (2 kg). This extract was then
dissolved in water to form a suspension, partitioned
with petroleum ether (20 L×3 times), dichloromethane
(20 L×3 times), n-butanol (20 L×3 times), respectively,
and then evaporated under reduced pressure at 60°C to
yield the petroleum fraction (346 g), dichloromethane
fraction (277 g), n-butanol fraction (532 g), and water
fraction (489 g).
For the MTT assay, an S180 tumor model was used to
evaluate their antitumor agents. The results suggested
that the antitumor agents were mainly contained in the
dichloromethane fraction. Further experiments were
performed on the dichloromethane extract to isolate the
antitumor compounds. The dichloromethane fraction
was subjected to column chromatography to yield 10
fractions. An activity-directed isolation process was used
to obtain the compounds, and 12 known compounds
with one new compound (genkwanin VIII) were isolated
from this fraction.
The new structure was elucidated by modern spectro-
scopic techniques including 1H-NMR (500 MHz), 13C-NMR
(125 MHz), 2D-NMR, and MS. The known compounds
were identified by comparing their 1H-NMR (400/500 MHz)
and 13C-NMR (100/125 MHz) data with those of authentic
samples or with those reported in literatures. The purity
of each compound exceeded %.
Genkwanin VIII (13): White amorphous, its molecular
formula was assigned to be C34H40O10, according to itsMCF-7 COLO 205 A 549 AGS HT-29
IC50 μg/mL
15 3 >60 17 23
>60 >60 34 >60 >60
48 34 >60 12 29
10 2 3 16 13
>60 >60 >60 34 >60
>60 >60 – >60 >60
40 >60 – 43 >60
43 >60 – >60 >60
>60 >60 – >60 >60
>60 >60 – >60 >60
>60 57 – >60 >60
>60 >60 – >60 >60
>60 >60 – >60 >60
Flos Genkwa on the proliferation of MDA-MB-231, Huh 7, AGS, Colo 205, MCF-7,
for 24 h.
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H40O10Na, 631.2519) and NMR results. Analysis of its
13C NMR and DEPT spectra (Table 2) established the
presence of 34 carbon resonances, including 3 methyls,
4 methylenes (1 oxygenated), 18 methines (4 oxygen-
ated), and 9 quaternary carbons (2 carbonyls and 4 oxy-
genated). The 1H and 13C NMR spectroscopic data
(Table 2) of compound 13 were similar to those of
genkwanin III [15], a daphnane-type diterpene ester,
except for the additional benzoyl group, with signals atTable 2 NMR spectroscopic data of genkwanin VIII
Position δH(J in Hz) δC
1 1.27(1H, m) 34.9
1.96(1H, m)
2 2.31(1H, m) 31.9
3 4.23(1H, d, J=10 Hz) 74.2
4 90.2
5 4.74(1H, s) 84.3
6 83.2
7 4.28(1H, s) 80.4
8 2.56(1H, s) 45.4
9 72.3
10 1.99(1H, m) 48.9
11 1.54(1H, m) 35.5
12 1.76(1H, m) 35.3
2.09(1H, m)
13 74.6
14 5.92(1H, s) 72.2
15 145.3
16 5.18(1H, s) 114.5
5.17(1H, s)
17 1.91(3H, s) 19.2
18 0.92(3H, d, J=6.56 Hz) 13.5
19 0.97(3H, d, J=7.12 Hz) 15.9




3´7´ 8.06(2H, d, J=8 Hz) 130.0
4´6´ 7.37(2H, m) 128.5
5´ 7.61(1H, t, J=7.5 Hz), 133.2
1″ 166.4
2″ 129.7
3″7″ 7.91(2H, d, J=7.5 Hz) 129.6
4″6″ 7.51(2H, t, J=7.5 Hz) 128.3
5″ 7.48(1H, m) 133.0
Table 2: All values given in ppm downfield from TMS were determined in CDCl3 atδH 7.91 (2H, d, J=7.5 Hz, H-3", 7"), 7.51(2H, t,
J=7.5 Hz, H-4", 6"), and 7.48(1H, m, H-5"); δC 166.4 (C-
1"), 129.7(C-2"), 129.6 (C-3", 7"), 128.3 (C-4", 6"), and
133.0 C-5"). In the 1H-NMR spectrum of 13, the
methine proton signal of H-14 shift downfield from δH
4.1 (1H, brs) to 5.92 (1H, s), indicating that the benzoyl
moiety was located at C-14. This result was further
confirmed by the HMBC experiment for 13. The key
correlation from H-14 to C-1″ was observed. The con-
figuration of 13 was elucidated by NOESY experimentHMBC(1H to 13C) NOSEY
2, 10, 19
2
4, 5, 9, 20 8
6, 7, 9 1, 17
1, 4, 9
7, 8, 9, 12, 13, 15, 1″ 7, 8, 16, 17





1H-NMR (400 MHz), 13C-NMR (100 MHz).
Figure 1 Molecular structure of genkwanine VIII (13).
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genkwanin III with α-orientations of H-2, H-10, 9-OH,
13-OH, and O-4, 14, and β-orientations of 3-OH, 5-
OH, H-7, and H-8. Thus, compound 13 was assigned
as shown in Figure 1 and named genkwanine VIII.
Biological evaluation
The potential effect of the Flos Genkwa extracts were in-
vestigated on the viability of MCF-7, HT-29, MDA-MB-
231, Huh 7, Colo 205, A549, AGS, A 2058, and B 16
cells using MTT assay with DMSO as the negative con-
trol. Cell cytotoxicity was tested in the concentration
range of 0 μg/mL to 50 μg/mL (Table 3) for each extract.
The results showed that the petroleum ether fraction ex-
hibits potential cytotoxic effects in the A 2058, Colo
205, and AGS cell lines at the IC50 levels of 89 μg/mL to
306 μg/mL, and the dichloromethane fraction possesses
potential cytotoxic effects in the A 2058, B 16, MCF-7,
Colo 205, and HT 29 cell lines at the IC50 levels of
50 μg/mL to 289 μg/mL. The inhibition of extracts onTable 3 Cytotoxic effects of the tested extracts
Huh 7 A 2058 B 16 231
Crude extract >500 97 >500 >500
Petroleum ether >500 89 >500 >500
Dichloromethane >500 50 98 >500
n-butanol >500 >500 >500 >500
Water >500 >500 >500 >500
Inhibitory effects of the extracts from the Flos Genkwa on the proliferation of MDA-
Cells were treated with 0–50 μg/mL of extracts for 24 h.the growth of transplanted mouse sarcoma S180 in mice
is shown in Figure 2. Compared with the CMC-Na
group, the dichloromethane fraction (500 mg/kg) signifi-
cantly (P<0.05) inhibited the growth of S180 solid tu-
mors, whereas other fractions (500 mg/kg) had no
apparent effect. These results suggested that most of the
antitumor constituents were in the dichloromethane
fraction.
Compounds isolated from the dichloromethane frac-
tion of Flos Genkwa were tested for cytotoxicity in the
nine cancer cell lines for 24 h. Considering that a com-
pound usually exhibits better efficacy than an extract,
each single compound was assessed at the dose range
0 μg/mL to 20 μg/mL. The results showed that daph-
nane-type diterpene esters (yuanhuacine, yuanhuadine,
genkwanine III, and genkwanine VIII) exhibited strong
cytotoxic effects in these cell lines at the IC50 levels
ranging from 2 μg/mL to 58 μg/mL than the other
compounds. Meanwhile, six of the compounds (daph-
noretin, genkwanin, 3′-hydroxygenkwanin, tiliroside,
syringaresinol, and aurantiamide acetate) showed mo-
derate IC50 values in six cancer cell lines (Table 1). Re-
sults suggested that daphnane-type diterpene esters are
important constituents in the extract responsible for
the anti-cancer activity of Flos Genkwa.
Yuanhuacine was investigated to further elucidate the
preliminary mechanism of daphnane-type diterpene es-
ters and to characterize its chemotherapeutic potential
effect. Yuanhuacine possessed the significant cytotoxic
effect in the MCF7 cell line. To determine whether the
cytotoxicity activity of yuanhuacine is related to the in-
duction of apoptosis, the apoptosis ratios in tumor cells
were quantitatively assessed by flow cytometric analysis.
As a result, a special DNA peak that is usually called the
sub-G1 peak or apoptotic peak appeared. As shown in
Figure 3, the apoptotic peak of the yuanhuacine-treated
MCF-7 cells was significantly higher than that of the
control cells, suggesting that yuanhuacine induces apop-
tosis in MCF-7 cells. The effect of yuanhuacine on the
expression in MCF-7 cells was measured by Western
blot analysis (Figure 4). MCF-7 cells were treated with
0 μg/mL to 20 μg/mL of yuanhuacine for 24 h. The Bcl-MCF-7 COLO 205 A 549 AGS HT-29
IC50 μg/mL
>500 >500 260 >500 >500
>500 306 >500 217 >500
260 289 >500 >500 50
>500 >500 >500 >500 >500
>500 431 >500 >500 >500
MB-231, Huh 7, AGS, Colo 205, MCF-7, HT-29, A 549, A 2058 and B 16 cells.
Figure 2 Effect of the fractions on mice transplanted with solid tumors.
Figure 3 Flow cytometric analysis of yuanhuacine.
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Figure 4 Effect of yuanhuacine on protein expressions in MCF7 cells.
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cludes both anti-apoptotic members such as Bcl-2 and
pro-apoptotic members such as Bax. Expression of the
anti-apoptotic protein Bcl-2 decreased, whereas Bax and
cleavage of PARP expression increased after treatment
with yuanhuacine. Moreover, FasL expression also in-
creased. The results suggest that yuanhuacine induced
apoptosis via the regulation of multiple signaling path-
ways toward an increment of death signals.Conclusion
In this study, an activity-directed fraction and purifica-
tion process were used to isolate antitumor com-
pounds from the flower buds of D. genkwa. The
dichloromethane fraction exhibited good antitumor ac-
tivities, consequently leading to the isolation of 13
compounds identified as daphnoretin (1), genkwanin
(2), 3′-hydroxygenkwanin (3), apigenin (4), tiliroside
(5), pinoresinol (6), syringaresinol (7), lariciresinol (8),
aurantiamide acetate (9), yuanhuacine (10), yuanhuadine
(11), genkwanine III (12), and genkwanine VIII (13).
Genkwanin VIII was found to be a new compound.
Through the MTT anti-cancer activity assay, daphnane di-
terpene esters showed stimulatory activity. The results
suggested that daphnane-type diterpene esters may be the
dominant constituents of antitumor activity in Flos
Genkwa. This is the first systematic study of extracts and
compounds from D. genkwa guided by the anti-tumor
activity screen of tumor cell lines and S180 tumor
models. Yuanhuacine was selected for the preliminary
mechanism in the MCF-7 cell line. Results showed that
yuanhuacine induced apoptosis via the regulation of
multiple signaling pathways toward an increment of
death signals.A material basis for the anti-cancer effect of Flos
Genkwa is provided and the scientific basis for the fur-
ther investigation of these daphnane-type diterpene es-
ters on their antitumor activities is strengthened.
Experimental
General procedures and reagents
1H-NMR, 13C-NMR, and 2D-NMR were recorded using
a Bruker spectrometer at 25°C, with tetramethylsilane as
the internal standard and CDCl3, DMSO-d6, or CD3OD
as the solvent. Colum chromatography was performed
using silica gel (100 to 200 mesh) (Qingdao Marine
Chemistry Co., Qingdao, China), Sephadex LH-20 (GE
Healthcare Bio Sciences AB, Uppsala, Sweden), and
MCI-gel CHP 20P (Mitsubishi Chemical Corp., Tokyo
Met, Japan). All other chemicals were of analytical re-
agent grade and used without further purification.
Plant materials
The buds of D. genkwa were collected from Bozhou,
Anhui Province, China and were authenticated by Prof.
Zhili Zhao of Shanghai University of Traditional Chinese
Medicine, Institute of Chinese Materia Medica.
Extraction and isolation
The dried flower buds of D. genkwa (20.0 kg) were
extracted with 95% ethanol extensively at room
temperature and evaporated to dryness to yield a dark
crude ethanol extract (2 kg). The extract was dissolved in
water to form a suspension and partitioned with petroleum
ether (20 L×3), dichloromethane (20 L×3), n-butanol
(20 L×3) successively and then evaporated under reduced
pressure at 60°C to afford the petroleum fraction
(346 g), dichloromethane fraction (277 g), n-butanol
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was subjected to column chromatography with petrol-
eum ether containing increasing amounts of acetic
ether using a silica gel column to obtain aurantiamide
acetate (9, 30 mg) and 10 fractions (Fr. 1–10). Fr. 3
was separated by MCI gel (CHP-20P) column chroma-
tography using gradient elution from methanol/water,
30:70, to methanol/water, 100:0, to give genkwanin (2,
60 mg), 3′-hydroxygenkwanin (3, 35 mg) and 5 fractions
(Fr. A-E). Fr. B and C were purified by chromatography
over silica gel column using dichloromethane-methanol
(9:1) to yield pinoresinol (6, 15 mg), daphnoretin (1,
8 mg) and syringaresinol (7, 20 mg). Fr. 5 was sepa-
rated by column chromatography on silica gel eluting
with dichloromethane-methanol (8:1) to give apigenin
(4, 27 mg) and 3 fractions (Fr. F-H). Fr. G was further
purified by chromatography over Sephadex LH-20 col-
umn eluting with methanol to give yuanhuacine (10,
19 mg), yuanhuadine (11, 23 mg). Fr. 6 was separated
by column chromatography on MCI gel (CHP-20P)
and Sephadex LH-20 using gradient elution from
methanol/water, 30:70, to methanol/water, 100:0, to
give tiliroside (5, 10 mg), pinoresinol (6, 10 mg) and
genkwanine VIII (13, 11 mg). Fr. 7 was purified by col-
umn chromatography over Sephadex LH-20 eluting
with methanol to give lariciresinol (8, 10 mg).Spectroscopic data
The NMR Data of Genkwanin VIII and the known com-
pounds were in the Table 2 and Additional file 1.Cell lines and culture
MDA-MB-231 (breast cancer cell line) was cultured in
DMEM supplemented with 10% FBS (fetal bovine
serum), 2 mM glutamine, 100 units/mL penicillin,
100 μg/mL streptomycin, 100 μg/mL neomycin at 37°C
in an incubator containing 5% CO2.
Huh7 cells (human hepatocellular carcinoma cells;
ATCC, Bethesda, MD) were grown in 90% DMEM
supplemented with 10% FBS, 2 mM glutamine, 1.5 g/L
sodium bicarbonate, 0.1 mM non-essential amino acids,
1.0 mM sodium pyruvate, 100 units/mL of penicillin,
and 100 μg/mL of streptomycin.
AGS cells (human gastric cancer cells) and Colo 205
cells (human colorectal carcinoma cells; ATCC, Be-
thesda, MD) were cultured in RPMI 1640 medium
supplemented with 10% FBS, 100 units/mL of penicillin,
and 100 μg/mL of streptomycin at 37°C in an incubator
containing 5% CO2.
MCF-7, HT-29 cells, and B 16 cells were cultured in
DMEM medium supplemented with 10% FBS, 100
units/mL of penicillin, and 100 μg/mL of streptomycin
at 37°C in an incubator containing 5% CO2.A549 cells (human non-small-cell lung cancer cell line)
were cultured in RPMI 1640 supplemented with 10% FBS,
100 units/mL of penicillin, 100 μg/mL of streptomycin, G
sodium, and 250 ng/mL of amphothericin B at 37°C in an
incubator containing 5% CO2.
A2058 was cultured in DMEM medium supplemented
with 10% FBS and 1% glutamine at 37 C in an incubator
containing 5% CO2.
MTT assay
All of the tested extracts and compounds were dissolved
in DMSO and subsequently diluted in the culture
medium before the cultured cells were treated. The cells
were seeded in 24-well plates at a density. After 24 h,
the culture medium was replaced with 1000 μL of serial
dilution (0 μg to 20 μg/0 μg to 50 μg) of samples, and
the solvent was incubated for 24 h. The final concentra-
tion of the solvent was <0.1% in the cell culture medium.
MTT (400 μL of 0.5 mg/mL) in PBS was added to each
well. After incubation at 37°C for 4 h, the unreacted dye
was removed, an equal cell culture volume of 10% SDS
(400 μL) was added to dissolve the MTT formazan, and
the absorbance was determined at 570 nm (A570). Cell
viability (%) was calculated as follows: (A570 of treated
cells/A570 of untreated cells) × 100.
Experimental animals
Kunming mice weighing 18 g to 22 g with equal num-
bers of males and females were purchased from Shang-
hai SLAC Laboratory Animal Co., Ltd. These animals
were used in accordance with the PR China legislation
on the use and care of laboratory animals and approved
by the Experimental Animal Ethical Committee of
Shanghai University of Traditional Chinese Medicine.
Murine sarcoma S180 cell line was obtained from SLAC
Laboratory and reproduced in our laboratory.
Preparation of S180 tumor-bearing mice
Mouse sarcoma S180 cell line was harvested and the
cells were resuspended in NS at 1.0 × 107 cells/mL to
1.3 × 107 cells/mL. Fifty Kunming mice weighing 18 g to
22 g with equal numbers of males and females were used
and subcutaneously implanted with 1.0 mL/mouse on
the right flank. At 24 h after inoculation, the mice were
randomly divided in five groups. 5-Fu-treated mice were
injected intraperitoneally with 5-Fu as a positive drug at
a dose of 25 mg/kg once every other day. Normal and
control (tumor-inoculated) group of mice received a
daily oral administration of 0.5% CMC-Na (0.2 mL/kg).
The treated groups received the indicated concentrations
of dichloromethane fraction (20 mg/mL to 700 mg/mL)
by intragastric administration for 14 d starting from
24 h after tumor inoculation. At 15 d, all of the mice
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Western blot analysis
Approximately 1 × 106 MCF-7 cells per 60 mm dish
were grown in DMEM medium supplemented with 10%
FBS, 100 units/mL of penicillin, and 100 μg/mL of
streptomycin to form a nearly confluent monolayer. The
cells were incubated with a maximum of 20 μg/mL of
yuanhuacine for 24 h, detached and washed once in cold
PBS, and resuspended in 100 μL of lysis buffer [10 mM
Tris–HCl (pH 8), 0.32 M sucrose, 1% Triton X-100,
5 mM EDTA, 2 mM dithiothreitol, and 1 mM phenyl-
methyl sulfonyl fluoride]. The suspension was placed in
an ice bath for 20 min and then centrifuged at 16,000 ×
rpm for 20 min at 4°C. Total protein content was deter-
mined using a Bio-Rad protein assay reagent with bovine
serum albumin as the standard. Protein extracts were
reconstituted in a sample buffer [0.062 M Tris–HCl, 2%
sodium dodecyl sulfate (SDS), 10% glycerol, and 5% β-
mercaptoethanol]. The mixture was then boiled for
5 min. Equal amounts of the denatured proteins were
loaded into each lane and separated on 8% to 15% SDS
polyacrylamide gels. Afterward, the proteins were trans-
ferred to polyvinylidene difluoride membranes overnight.
These membranes were blocked with 0.1% Tween-20 in
PBS containing 5% non-fat dried milk for 20 min at
room temperature, allowed to react with primary an-
tibodies for 2 h, and incubated with a horseradish
peroxidase-conjugated goat anti-rabbit or anti-mouse
antibody for 2 h before these membranes were devel-
oped using SuperSignal ULTRA chemiluminescence
substrate (Pierce, Rockford, IL). Band intensities were
quantified by densitometry at an absorbance of 540 nm
determined using an enzyme-linked immunosorbent
assay plate reader.
Flow cytometric analysis
Cellular DNA content was determined by flow
cytometric analysis of propidium iodide (PI)-labeled
cells. MCF-7 cells (4 × 105 cell/60 mm dish) were incu-
bated with yuanhuacine (0, 5, 15, and 20 μg/mL) for
24 h. The cells were then collected by trypsinization and
fixed in ice-cold 70% ethanol at −20°C overnight. The
cells were resuspended in PBS containing 1% Triton X-
100, 0.5 mg/mL of RNase and 4 μg/mL of PI at 37°C for
30 min. An FACS Calibur flow cytometer equipped with
a single argon-ion laser (488 nm) was used for flow
cytometric analysis. The cell cycle was determined and
analyzed using Mod Fit software.
Statistical analysis
Statistical analyses were performed in SPSS 11.0 and the
data were analyzed using one-way ANOVA. The meanseparations were performed using the least significant
difference method. Each experiment was performed in
triplicate, and all of the experiments were run thrice and
yielded similar results. Measurements from all the repli-
cates were combined and the treatment effects were
analyzed.
Additional file
Additional file 1: Spectra report of compound 1-13.
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